Notice of Intent to Sole Source--POLYSERP™, a Non-FDA Approved Polyvalent F(ab')2 Immunoglobulin Fragments (Equine) Snake Antivenom
Closed Special Notice Posted
- Solicitation number
- W81XWH22R0083
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
Notice text
The United States Army Medical Research Acquisition Activity (USAMRAA) intends to issue a sole source contract under the authority of FAR 13.106(b)(1) – Soliciting from a single source for purchases not exceeding the simplified acquisition threshold and only one source is reasonably available, on or about 19 August 2022 to CRO, LLC, 516 E. Spruce St., Missoula, MT 59802 under NAICS 325414 Biological Product (except Diagnostics) Manufacturing.
The US Army Medical Materiel Development Activity (USAMMDA) Force Health Protection (FHP) Directorate has a requirement for: one (1) shipment of Polyvalent F(ab’)2 Immunoglobulin Fragments (Equine), Snake Antivenom for multiple African nations.
See attachment for details.
Files
| File | Type | Posted |
|---|---|---|
| NOI-to-Sole-Source_W81XWH-22-R-0083_POLYSERP-Snake-Antivenom(2).docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity